ENTRY       D01025                      Drug
NAME        Levobunolol hydrochloride (JAN/USP);
            Betagan (TN)
PRODUCT
  GENERIC   LEVOBUNOLOL HYDROCHLORIDE (Bausch & Lomb Incorporated)
FORMULA     C17H25NO3. HCl
EXACT_MASS  327.1601
MOL_WEIGHT  327.8462
CLASS       Cardiovascular agent
             DG01466  Adrenergic receptor antagonist
              DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
            Ophthalmic agent
             DG03201  Intraocular pressure lowering agent
REMARK      Therapeutic category: 1319
            ATC code: S01ED03
            Chemical structure group: DG01136
            Product (DG01136): D01025<JP/US>
EFFICACY    Antiglaucoma, alpha1/beta-Adrenergic receptor antagonist
  DISEASE   Open-angle glaucoma [DS:H00612]
COMMENT     Propranolol derivative
TARGET      ADRB [HSA:153 154 155] [KO:K04141 K04142 K04143]
            ADRA1 [HSA:148 147 146] [KO:K04135 K04136 K04137]
  PATHWAY   hsa04020(146+147+148+153+154+155)  Calcium signaling pathway
            hsa04080(146+147+148+153+154+155)  Neuroactive ligand-receptor interaction
INTERACTION  
STR_MAP     map07054  Antiglaucoma agents
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             S SENSORY ORGANS
              S01 OPHTHALMOLOGICALS
               S01E ANTIGLAUCOMA PREPARATIONS AND MIOTICS
                S01ED Beta blocking agents
                 S01ED03 Levobunolol
                  D01025  Levobunolol hydrochloride (JAN/USP) &lt;JP/US&gt;
            USP drug classification [BR:br08302]
             Ophthalmic Agents
              Intraocular Pressure Lowering Agents
               Beta-adrenergic Blocking Agents, Ophthalmic
                Levobunolol
                 D01025  Levobunolol hydrochloride (JAN/USP)
            Therapeutic category of drugs in Japan [BR:br08301]
             1  Agents affecting nervous system and sensory organs
              13  Agents affecting sensory organs
               131  Ophthalmic agents
                1319  Others
                 D01025  Levobunolol hydrochloride (JAN/USP)
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
                DG01136  Levobunolol
                 D01025  Levobunolol hydrochloride
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG01136  Levobunolol
                D01025  Levobunolol hydrochloride
            Drug classes [BR:br08332]
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               D01025  Levobunolol hydrochloride
            Target-based classification of drugs [BR:br08310]
             G Protein-coupled receptors
              Rhodopsin family
               Adrenaline
                ADRA1
                 D01025  Levobunolol hydrochloride (JAN/USP) &lt;JP/US&gt;
                ADRB
                 D01025  Levobunolol hydrochloride (JAN/USP) &lt;JP/US&gt;
            New drug approvals in Japan [br08318.html]
             Drugs with new active ingredients
              D01025
            Drug groups [BR:br08330]
             Cardiovascular agent
              DG01466  Adrenergic receptor antagonist
               DG01464  beta-Adrenergic receptor antagonist (Beta blocker)
                DG01136  Levobunolol
             Ophthalmic agent
              DG03201  Intraocular pressure lowering agent
               DG01136  Levobunolol
DBLINKS     CAS: 27912-14-7
            PubChem: 7848088
            ChEBI: 6439
            LigandBox: D01025
            NIKKAJI: J243.812G
ATOM        22
            1   X   Cl   27.6087  -32.8813
            2   C1d C    27.4400  -26.6700
            3   C1a C    28.6524  -27.3700
            4   N1b N    26.2276  -27.3700
            5   C1b C    25.0321  -26.6796
            6   C1c C    23.8447  -27.3651
            7   C1b C    22.6535  -26.6771
            8   O2a O    21.4640  -27.3638
            9   C1a C    27.4400  -25.2700
            10  C1a C    28.6524  -25.9700
            11  O1a O    23.8445  -28.7698
            12  C8y C    21.4640  -28.7638
            13  C8y C    20.2686  -29.4542
            14  C8y C    20.2689  -30.8542
            15  C8x C    21.4814  -31.5540
            16  C8x C    22.6768  -30.8636
            17  C8x C    22.6766  -29.4636
            18  C1x C    19.0560  -28.7545
            19  C1x C    17.8437  -29.4547
            20  C1x C    17.8440  -30.8547
            21  C5x C    19.0566  -31.5545
            22  O5x O    19.0570  -32.9699
BOND        22
            1     2   3 1
            2     2   4 1
            3     4   5 1
            4     5   6 1
            5     6   7 1
            6     7   8 1
            7     2   9 1
            8     2  10 1
            9     6  11 1 #Down
            10    8  12 1
            11   12  13 2
            12   13  14 1
            13   14  15 2
            14   15  16 1
            15   16  17 2
            16   12  17 1
            17   13  18 1
            18   18  19 1
            19   19  20 1
            20   20  21 1
            21   14  21 1
            22   21  22 2
///
